Cardiorespiratory effects of tiletamine/zolazepam in dogs (Canis familiaris) given acepromazin

Detalhes bibliográficos
Autor(a) principal: Almeida, Ellen Maria Pestili de
Data de Publicação: 2000
Outros Autores: Nunes, Newton, Fantinatti, Alexandra Pinheiro, Santos, Paulo Sérgio Patto dos, Bolzan, Aline Adriana, Rezende, Márlis Langenegger de
Tipo de documento: Artigo
Idioma: por
Título da fonte: Brazilian Journal of Veterinary Research and Animal Science
Texto Completo: https://www.revistas.usp.br/bjvras/article/view/5817
Resumo: The aim of this work was to evaluate the use of acepromazine as pre-treatment to tiletamine/zolazepam association. Twenty male and female healthy adult mixed breed dogs were used. The dogs were allocated in two groups of 10 animals each (G1 and G2). To G1 was administered 0.1 ml/kg of saline at 0.9 % (placebo), followed by 10 mg/kg of tiletamine/zolazepam 20 minutes later, both intravenously. Immediately before the pre-anesthetic medication (M1), before the anesthetic’s application (M2) and at 15, 30, 45 and 60 minutes after the administration of tiletamine/zolazepam association (M3 to M6, respectively), measurements of heart rate (HR), systolic, diastolic and mean blood pressures (SBP, DBP e MBP, respectively), cardiac output (CO), cardiac index (CI), systolic volume (SV), electrocardiogram (ECG), respiratory rate (RR), end tidal CO2 (ETCO2), oxihemoglobin saturation (SpO2) and body temperature (T0) were realized. For G2 the same methodology was used, replacing the placebo by acepromazine, at 0.2 mg/kg. The numeric data were submitted to analysis of profile that demonstrated cardiovascular stability and an increase of the anesthetic period with the use of acepromazine, and it was also observed, in G2, that, in spite of the decrease of RR, the SpO2 and ETCO2 values didn’t have significant alterations, allowing to conclude that the use of acepromazine presents advantages in the isolated use of the tiletamine/zolazepam association, in dogs.
id USP-49_68f6afb56c765c566341b673e8e689f9
oai_identifier_str oai:revistas.usp.br:article/5817
network_acronym_str USP-49
network_name_str Brazilian Journal of Veterinary Research and Animal Science
repository_id_str https://www.revistas.usp.br/bjvras/index
spelling Cardiorespiratory effects of tiletamine/zolazepam in dogs (Canis familiaris) given acepromazinEfeitos cardiorrespiratórios da associação de tiletamina/zolazepam em cães (Canis familiaris) pré-tratados ou não pela acepromazinaCãoAcepromazinaTiletaminaZolazepamAnestesiaDogsAcepromazineTiletamineZolazepamAnaesthesiaThe aim of this work was to evaluate the use of acepromazine as pre-treatment to tiletamine/zolazepam association. Twenty male and female healthy adult mixed breed dogs were used. The dogs were allocated in two groups of 10 animals each (G1 and G2). To G1 was administered 0.1 ml/kg of saline at 0.9 % (placebo), followed by 10 mg/kg of tiletamine/zolazepam 20 minutes later, both intravenously. Immediately before the pre-anesthetic medication (M1), before the anesthetic’s application (M2) and at 15, 30, 45 and 60 minutes after the administration of tiletamine/zolazepam association (M3 to M6, respectively), measurements of heart rate (HR), systolic, diastolic and mean blood pressures (SBP, DBP e MBP, respectively), cardiac output (CO), cardiac index (CI), systolic volume (SV), electrocardiogram (ECG), respiratory rate (RR), end tidal CO2 (ETCO2), oxihemoglobin saturation (SpO2) and body temperature (T0) were realized. For G2 the same methodology was used, replacing the placebo by acepromazine, at 0.2 mg/kg. The numeric data were submitted to analysis of profile that demonstrated cardiovascular stability and an increase of the anesthetic period with the use of acepromazine, and it was also observed, in G2, that, in spite of the decrease of RR, the SpO2 and ETCO2 values didn’t have significant alterations, allowing to conclude that the use of acepromazine presents advantages in the isolated use of the tiletamine/zolazepam association, in dogs.Avaliou-se o uso da acepromazina como pré-tratamento à associação de tiletamina/zolazepam. Para tanto, utilizaram-se 20 animais da espécie canina, machos e fêmeas, adultos, hígidos, divididos em 2 grupos de igual número. O grupo 1 (controle) foi pré-tratado com 0,1 ml/kg de solução salina a 0,9 % e o grupo 2 com 0,2 mg/kg de acepromazina, ambos por via intravenosa. Decorridos 20 minutos, todos os animais receberam, pela mesma via, 10 mg/kg da associação tiletamina/zolazepam. Imediatamente antes da medicação pré-anestésica (M1), antes da aplicação da associação (M2) e aos 15, 30, 45 e 60 minutos após a administração da tiletamina/zolazepam, realizou-se mensuração de: freqüência cardíaca (FC); pressão arterial sistólica (PAS), diastólica (PAD) e média (PAM); débito (DC) e índice cardíaco (IC); volume sistólico (VS); eletrocardiograma (ECG); freqüência respiratória (FR); CO2 ao final da expiração (ETCO2); saturação da oxiemoglobina (SpO2); e temperatura retal (T0). Observou-se estabilidade cardiovascular, miorrelaxamento e aumento do período hábil anestésico com o uso da acepromazina na medicação pré-anestésica. O tratamento estatístco dos valores numéricos pela análise de perfil mostrou que a acepromazina diminuiu a FR; entretanto, a SpO2 e ETCO2 não sofreram alterações estatisticamente significativas, permitindo concluir que o emprego da fenotiazina apresenta vantagens sobre o uso isolado da associação tiletamina/zolazepam, em cães.Universidade de São Paulo. Faculdade de Medicina Veterinária e Zootecnia2000-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjvras/article/view/581710.1590/S1413-95962000000300007Brazilian Journal of Veterinary Research and Animal Science; Vol. 37 Núm. 3 (2000); 210-215Brazilian Journal of Veterinary Research and Animal Science; Vol. 37 No. 3 (2000); 210-215Brazilian Journal of Veterinary Research and Animal Science; v. 37 n. 3 (2000); 210-215Brazilian Journal of Veterinary Research and Animal Science; V. 37 N. 3 (2000); 210-2151678-44561413-9596reponame:Brazilian Journal of Veterinary Research and Animal Scienceinstname:Faculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo (FMVZ-USP)instacron:USPporhttps://www.revistas.usp.br/bjvras/article/view/5817/62470Almeida, Ellen Maria Pestili deNunes, NewtonFantinatti, Alexandra PinheiroSantos, Paulo Sérgio Patto dosBolzan, Aline AdrianaRezende, Márlis Langenegger deinfo:eu-repo/semantics/openAccess2020-06-23T04:41:41Zoai:revistas.usp.br:article/5817Revistahttps://www.revistas.usp.br/bjvrasPUBhttps://www.revistas.usp.br/bjvras/oaibjvras@usp.br1413-95961413-9596opendoar:https://www.revistas.usp.br/bjvras/index2023-01-12T16:42:23.919536Brazilian Journal of Veterinary Research and Animal Science - Faculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo (FMVZ-USP)false
dc.title.none.fl_str_mv Cardiorespiratory effects of tiletamine/zolazepam in dogs (Canis familiaris) given acepromazin
Efeitos cardiorrespiratórios da associação de tiletamina/zolazepam em cães (Canis familiaris) pré-tratados ou não pela acepromazina
title Cardiorespiratory effects of tiletamine/zolazepam in dogs (Canis familiaris) given acepromazin
spellingShingle Cardiorespiratory effects of tiletamine/zolazepam in dogs (Canis familiaris) given acepromazin
Almeida, Ellen Maria Pestili de
Cão
Acepromazina
Tiletamina
Zolazepam
Anestesia
Dogs
Acepromazine
Tiletamine
Zolazepam
Anaesthesia
title_short Cardiorespiratory effects of tiletamine/zolazepam in dogs (Canis familiaris) given acepromazin
title_full Cardiorespiratory effects of tiletamine/zolazepam in dogs (Canis familiaris) given acepromazin
title_fullStr Cardiorespiratory effects of tiletamine/zolazepam in dogs (Canis familiaris) given acepromazin
title_full_unstemmed Cardiorespiratory effects of tiletamine/zolazepam in dogs (Canis familiaris) given acepromazin
title_sort Cardiorespiratory effects of tiletamine/zolazepam in dogs (Canis familiaris) given acepromazin
author Almeida, Ellen Maria Pestili de
author_facet Almeida, Ellen Maria Pestili de
Nunes, Newton
Fantinatti, Alexandra Pinheiro
Santos, Paulo Sérgio Patto dos
Bolzan, Aline Adriana
Rezende, Márlis Langenegger de
author_role author
author2 Nunes, Newton
Fantinatti, Alexandra Pinheiro
Santos, Paulo Sérgio Patto dos
Bolzan, Aline Adriana
Rezende, Márlis Langenegger de
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Almeida, Ellen Maria Pestili de
Nunes, Newton
Fantinatti, Alexandra Pinheiro
Santos, Paulo Sérgio Patto dos
Bolzan, Aline Adriana
Rezende, Márlis Langenegger de
dc.subject.por.fl_str_mv Cão
Acepromazina
Tiletamina
Zolazepam
Anestesia
Dogs
Acepromazine
Tiletamine
Zolazepam
Anaesthesia
topic Cão
Acepromazina
Tiletamina
Zolazepam
Anestesia
Dogs
Acepromazine
Tiletamine
Zolazepam
Anaesthesia
description The aim of this work was to evaluate the use of acepromazine as pre-treatment to tiletamine/zolazepam association. Twenty male and female healthy adult mixed breed dogs were used. The dogs were allocated in two groups of 10 animals each (G1 and G2). To G1 was administered 0.1 ml/kg of saline at 0.9 % (placebo), followed by 10 mg/kg of tiletamine/zolazepam 20 minutes later, both intravenously. Immediately before the pre-anesthetic medication (M1), before the anesthetic’s application (M2) and at 15, 30, 45 and 60 minutes after the administration of tiletamine/zolazepam association (M3 to M6, respectively), measurements of heart rate (HR), systolic, diastolic and mean blood pressures (SBP, DBP e MBP, respectively), cardiac output (CO), cardiac index (CI), systolic volume (SV), electrocardiogram (ECG), respiratory rate (RR), end tidal CO2 (ETCO2), oxihemoglobin saturation (SpO2) and body temperature (T0) were realized. For G2 the same methodology was used, replacing the placebo by acepromazine, at 0.2 mg/kg. The numeric data were submitted to analysis of profile that demonstrated cardiovascular stability and an increase of the anesthetic period with the use of acepromazine, and it was also observed, in G2, that, in spite of the decrease of RR, the SpO2 and ETCO2 values didn’t have significant alterations, allowing to conclude that the use of acepromazine presents advantages in the isolated use of the tiletamine/zolazepam association, in dogs.
publishDate 2000
dc.date.none.fl_str_mv 2000-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjvras/article/view/5817
10.1590/S1413-95962000000300007
url https://www.revistas.usp.br/bjvras/article/view/5817
identifier_str_mv 10.1590/S1413-95962000000300007
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjvras/article/view/5817/62470
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Medicina Veterinária e Zootecnia
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Medicina Veterinária e Zootecnia
dc.source.none.fl_str_mv Brazilian Journal of Veterinary Research and Animal Science; Vol. 37 Núm. 3 (2000); 210-215
Brazilian Journal of Veterinary Research and Animal Science; Vol. 37 No. 3 (2000); 210-215
Brazilian Journal of Veterinary Research and Animal Science; v. 37 n. 3 (2000); 210-215
Brazilian Journal of Veterinary Research and Animal Science; V. 37 N. 3 (2000); 210-215
1678-4456
1413-9596
reponame:Brazilian Journal of Veterinary Research and Animal Science
instname:Faculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo (FMVZ-USP)
instacron:USP
instname_str Faculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo (FMVZ-USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Veterinary Research and Animal Science
collection Brazilian Journal of Veterinary Research and Animal Science
repository.name.fl_str_mv Brazilian Journal of Veterinary Research and Animal Science - Faculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo (FMVZ-USP)
repository.mail.fl_str_mv bjvras@usp.br
_version_ 1797051555189358592